Darpan News Desk The Canadian Press, 28 Feb, 2022 01:15 PM
An Ontario court has extended to March 9 a freezing order on funds donated to the recent Ottawa convoy protest, as a class-action civil suit against protest organizers continues.
Parties in the case have agreed to move some donated funds and cryptocurrency into escrow, which could be redistributed to affected Ottawa residents and business owners should the class action succeed.
Norman Groot, a lawyer representing some convoy protest leaders, says ChristopherGarrah, Benjamin Dichter and Nicholas St. Louis have agreed in principle to moving donated funds within their control to an escrow account.
Groot notes the funds that Garrah, Dichter and St. Louis have agreed to move to escrow might not account for all the cryptocurrency that was donated, and he proposed parties meet next week to take stock of what has been transferred.
An escrow agent will oversee the transferred funds, and will be permitted to change the passwords for cryptocurrency.
The class-action lawsuit seeks a total of $306 million in damages related to the three-week anti-government convoy protest near Parliament Hill that snarled traffic, shut businesses and plagued residents with near-constant honking.
Speaking to Canadians from isolation after testing positive for COVID-19 Monday, Trudeau said "freedom of expression, assembly and association are cornerstones of democracy."
The official report on last September's election outlined multiple obstacles those running the election had to overcome because of COVID-19, including finding people to staff polling stations.
The $258,000 retirement allowance that her then-boss, former clerk Craig James, received in 2012 is the largest among several payments that are subject to criminal allegations of misspending that James denies.
Assistant Chief Brian Bertuzzi confirmed a child under 10 years old, their mother and grandfather were killed, while the grandmother and father suffered smoke inhalation.
The decision was bolstered by real-world evidence from the more than 200 million doses administered in the U.S. since the FDA cleared the shot in December 2020. The FDA granted full approval of Pfizer’s vaccine last August.
